Optimizing therapy for argininosuccinic aciduria.

about

One Year Experience of Pheburane(®) (Sodium Phenylbutyrate) Treatment in a Patient with Argininosuccinate Lyase Deficiency.Argininosuccinic aciduria: from a monogenic to a complex disorder.Aminoacidopathies: Prevalence, Etiology, Screening, and Treatment Options.

P2860

Q35848695-08F8F635-4393-4281-8DB2-354202686727 Q38073117-E1DC931B-CB1C-4601-B458-C16540D22103 Q47389266-C844EBEC-E922-4F4E-928D-12633988734A

P2860

Optimizing therapy for argininosuccinic aciduria.

Item

http://www.wikidata.org/entity/Q36240791

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Optimizing therapy for argininosuccinic aciduria.

@ast

Optimizing therapy for argininosuccinic aciduria.

@en

type

Item

label

Optimizing therapy for argininosuccinic aciduria.

@ast

Optimizing therapy for argininosuccinic aciduria.

@en

prefLabel

Optimizing therapy for argininosuccinic aciduria.

@ast

Optimizing therapy for argininosuccinic aciduria.

@en

P1476

Optimizing therapy for argininosuccinic aciduria.

@en

P2093

Ayelet Erez

http://www.w3.org/2001/XMLSchema#string

Brendan Lee

http://www.w3.org/2001/XMLSchema#string

Sandesh C S Nagamani

http://www.w3.org/2001/XMLSchema#string

P2860

Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening

Human argininosuccinate lyase: a structural basis for intragenic complementation

The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway

Crystal structure of an inactive duck delta II crystallin mutant with bound argininosuccinate

Recruitment of enzymes as lens structural proteins

Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl-D-aspartate receptor.

Nitrate and nitrite in biology, nutrition and therapeutics

Oxygen reduction by nitric-oxide synthases.

Enzymes of arginine metabolism.

Reactive oxygen species and the central nervous system.

P304

10-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2012.07.009

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22841516

http://www.w3.org/2001/XMLSchema#string

P932

3444682

http://www.w3.org/2001/XMLSchema#string

Optimizing therapy for argininosuccinic aciduria.

about

P2860

P2860

Optimizing therapy for argininosuccinic aciduria.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932